We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
-13.37%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$118M
AUM Growth
-$29.5M
Cap. Flow
-$2.14M
Cap. Flow %
-1.81%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ELGX
Endologix Inc
ELGX
+$2.14M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYTM icon
1
Rhythm Pharmaceuticals
RYTM
$7.07B
$82.7M 69.94%
3,074,893
CHMA
2
DELISTED
Chiasma, Inc. Common Stock
CHMA
$17.8M 15.1%
5,736,296
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$1.84B
$9.65M 8.17%
2,168,691
HSTO
4
DELISTED
Histogen Inc. Common Stock
HSTO
$4.26M 3.61%
12,324
TARA icon
5
Protara Therapeutics
TARA
$233M
$2.23M 1.89%
24,585
PETX
6
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.53M 1.3%
250,000
ELGX
7
DELISTED
Endologix Inc
ELGX
-112,145
Closed -$2.14M

Similar funds

MPM Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, MPM Asset Management held 7 positions worth $118M, down 20% from $148M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management's Q4 2018 filing shows 1 closed position. The largest sale was Endologix Inc, an estimated $2.14M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MPM Asset Management fully exited Endologix Inc in Q4 2018, selling an estimated $2.14M.
  • MPM Asset Management's ten largest holdings make up 100% of its $118M portfolio in Q4 2018.
  • MPM Asset Management opened 0 new positions and closed 1 in Q4 2018.
  • MPM Asset Management's portfolio value fell 20% quarter-over-quarter to $118M.

Based on MPM Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.